RJA
CORZ

Raymond James & Associates’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Raymond James & Associates’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-26,953
Closed -$35K – 4117
2022
Q3 		$35K Hold
26,953
– – ﹤0.01% 3744
2022
Q2 		$40K Sell
26,953
-4,725
-15% -$21.7K ﹤0.01% 3815
2022
Q1 		$261K Buy
31,678
+5,350
+20% +$47.3K ﹤0.01% 3502
2021
Q4 		$288K Buy
+26,328
New +$311K ﹤0.01% 3463

Other funds holding CORZ

PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
STA
Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Raymond James & Associates's CORZ Position: Q4 2022 in Review

Raymond James & Associates sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2022, closing a stake of 26,953 shares — an estimated $35K sold.

Raymond James & Associates first reported a position in CORZ in Q4 2021 and held it in 4 quarters. The position peaked at $288K in Q4 2021. 89 funds tracked by Wall St. Rank hold CORZ as of Q4 2022.

  • Raymond James & Associates reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Raymond James & Associates sold 26,953 Core Scientific, Inc. Common Stock shares in Q4 2022, an estimated $35K.
  • Raymond James & Associates first reported a position in Core Scientific, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Raymond James & Associates's Core Scientific, Inc. Common Stock position peaked at $288K in Q4 2021.
  • 89 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2022.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.